VanEck Pharmaceutical Financials
| PPH Etf | USD 90.01 0.61 0.68% |
Net Expense Ratio 0.0036 | 3 y Sharp Ratio 0.38 |
VanEck |
The data published in VanEck Pharmaceutical's official financial statements typically reflect VanEck Pharmaceutical's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving VanEck Pharmaceutical's quantitative information. For example, before you start analyzing numbers published by VanEck accountants, it's essential to understand VanEck Pharmaceutical's liquidity, profitability, and earnings quality within the context of the VanEck space in which it operates.
VanEck Pharmaceutical Etf Summary
VanEck Pharmaceutical competes with VanEck Biotech, VanEck Retail, IShares Healthcare, IShares Telecommunicatio, and VanEck Oil. The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index. Vaneck Pharmaceutical is traded on NASDAQ Exchange in the United States.| Instrument | USA Etf View All |
| Exchange | NASDAQ Exchange |
| ISIN | US92189F6925 |
| CUSIP | 92189F692 57060U217 71712A206 |
| Region | Global |
| Investment Issuer | Van Eck |
| Etf Family | VanEck |
| Fund Category | Sector |
| Portfolio Concentration | Health Care |
| Benchmark | Dow Jones Industrial |
| Phone | NA |
| Currency | USD - US Dollar |
VanEck Pharmaceutical Key Financial Ratios
VanEck Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining VanEck Pharmaceutical's current stock value. Our valuation model uses many indicators to compare VanEck Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across VanEck Pharmaceutical competition to find correlations between indicators driving VanEck Pharmaceutical's intrinsic value. More Info.VanEck Pharmaceutical ETF is rated number one ETF in price to earning as compared to similar ETFs. It also is rated number one ETF in price to book as compared to similar ETFs fabricating about 0.15 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for VanEck Pharmaceutical ETF is roughly 6.51 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the VanEck Pharmaceutical's earnings, one of the primary drivers of an investment's value.VanEck Pharmaceutical ETF Systematic Risk
VanEck Pharmaceutical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. VanEck Pharmaceutical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on VanEck Pharmaceutical ETF correlated with the market. If Beta is less than 0 VanEck Pharmaceutical generally moves in the opposite direction as compared to the market. If VanEck Pharmaceutical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one VanEck Pharmaceutical ETF is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of VanEck Pharmaceutical is generally in the same direction as the market. If Beta > 1 VanEck Pharmaceutical moves generally in the same direction as, but more than the movement of the benchmark.
About VanEck Pharmaceutical Financials
What exactly are VanEck Pharmaceutical Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include VanEck Pharmaceutical's income statement, its balance sheet, and the statement of cash flows. Potential VanEck Pharmaceutical investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although VanEck Pharmaceutical investors may use each financial statement separately, they are all related. The changes in VanEck Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on VanEck Pharmaceutical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.VanEck Pharmaceutical Thematic Clasifications
VanEck Pharmaceutical ETF is part of several thematic ideas from Sector ETFs to Health Care ETFs. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasVanEck Pharmaceutical November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of VanEck Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of VanEck Pharmaceutical ETF. We use our internally-developed statistical techniques to arrive at the intrinsic value of VanEck Pharmaceutical ETF based on widely used predictive technical indicators. In general, we focus on analyzing VanEck Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build VanEck Pharmaceutical's daily price indicators and compare them against related drivers.
| Information Ratio | (0.39) | |||
| Maximum Drawdown | 3.61 | |||
| Value At Risk | (1.46) | |||
| Potential Upside | 0.7429 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in VanEck Pharmaceutical ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Stocks Directory module to find actively traded stocks across global markets.
The market value of VanEck Pharmaceutical ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is VanEck Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Pharmaceutical's market value can be influenced by many factors that don't directly affect VanEck Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.